Synthesis of the antifungal beta-1,3-glucan synthase inhibitor CANCIDAS (caspofungin acetate) from pneumocandin B0.

J Org Chem

Process Research Department, Merck Research Laboratories, P.O. Box 2000, Rahway, New Jersey 07065-0900, USA.

Published: March 2007

AI Article Synopsis

  • - A new three-step method for synthesizing the antifungal drug CANCIDAS (caspofungin acetate) starting from pneumocandin B0 is detailed in the study.
  • - Key features of the synthesis involve creating a specific compound called phenylthioaminal, effectively reducing a primary amide in a single step with borane, and selectively substituting it with ethylenediamine.
  • - The overall yield of the final product, CANCIDAS, achieved through this synthesis is 45%, highlighting its efficiency.

Article Abstract

A novel three-step synthesis of the highly functionalized antifungal agent CANCIDAS (caspofungin acetate, 2) is described, starting from the natural product pneumocandin B0 (1). The highlights of the synthesis include a stereoselective formation of a phenylthioaminal, a remarkable chemoselective, high-yielding, one-step borane reduction of a primary amide, and a stereoselective substitution of the phenylthioaminal with ethylenediamine producing 2 in a 45% overall yield.

Download full-text PDF

Source
http://dx.doi.org/10.1021/jo062008iDOI Listing

Publication Analysis

Top Keywords

cancidas caspofungin
8
caspofungin acetate
8
synthesis antifungal
4
antifungal beta-13-glucan
4
beta-13-glucan synthase
4
synthase inhibitor
4
inhibitor cancidas
4
acetate pneumocandin
4
pneumocandin novel
4
novel three-step
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!